EHRA Premium Access

Clinical factors related to successful or unsuccessful cardioversion in the edoxaban versus warfarin in subjects undergoing cardioversion of atrial fibrillation (ENSURE-AF) randomized trial

Congress Presentation

About the speaker

Professor Gregory Yh Lip

University of Liverpool, Liverpool (United Kingdom of Great Britain & Northern Ireland)
94 presentations
9 followers

39 more presentations in this session

Determinants of progression of persistent to permanent atrial fibrillation - data from the RACE 3 study

Speaker: Doctor R. De With (Groningen, NL)

Thumbnail

The electrocardiographic and echocardiographic factors affecting infarct volume in acute ischaemic stroke

Speaker: Doctor D. Ranganathan (Dublin, IE)

Thumbnail

Impact of incomplete revascularization in atrial fibrillation patients undergoing percutaneous coronary intervention: the afcas registry

Speaker: Associate Professor M. Proietti (Milan, IT)

Thumbnail

Cryptogenic stroke is associated with atrial fibrosis similar to atrial fibrillation

Speaker: Professor N. Akoum (Seattle, US)

Thumbnail

Do we follow the recommendation of anticoagulation withdrawal after electrical cardioversion, in patients with atrial fibrillation?

Speaker: Doctor M. Vidal Burdeus (Barcelona, ES)

Thumbnail

Access the full session

Poster session 3 - Atrial fibrillation - Clinical

Speakers: Professor G. Lip, Doctor R. De With, Doctor D. Ranganathan, Associate Professor M. Proietti, Professor N. Akoum...
Thumbnail

About the event

Image

EHRA 2018

18 March - 20 March 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb